Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapoxetine, paroxetine, and tadalafil combination therapy for premature ejaculation
IRCT20190528043747N1Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dapoxetine, paroxetine and tadalafil in premature ejaculation (PE) (4 arms), sponsored by Ardabil University of Medical Sciences. Primary endpoint: Cured premature ejaculation. Started Aug 2019; status: completed.
02
Drugs
dapoxetineparoxetinetadalafil
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on IRCT20190528043747N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190528043747N1.